busulfan has been researched along with Antibody Deficiency Syndrome in 19 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "X-linked EDA-ID1 (ectodermal dysplasia, anhidrotic, with immunodeficiency 1, Online Mendelian Inheritance in Man [OMIM] 300291), or NEMO (nuclear factor kappa B essential modulator) deficiency syndrome, is caused by mutations in the IKBKG/NEMO gene." | 1.56 | Successful Allogeneic Stem Cell Transplantation in Nuclear Factor-Kappa B Essential Modulator Deficiency Syndrome After Treosulfan-Based Conditioning: A Case Report. ( Bąbol-Pokora, K; Dąbrowska-Leonik, N; Frączkiewicz, J; Gul, K; Janeczko-Czarnecka, M; Kałwak, K; Martuszewski, A; Mielcarek-Siedziuk, M; Młynarski, W; Nowak, M; Paluszkiewicz, P; Salamonowicz-Bodzioch, M; Sierżęga-Staykov, K; Ussowicz, M; Wawrzyniak-Dzierżek, E; Wolska-Kuśnierz, B, 2020) |
| "Busulfan was quantitated using ultraviolet absorbance detection after derivatization and HPLC separation." | 1.32 | Plasma pharmacokinetics of high-dose oral busulfan in children and adults undergoing bone marrow transplantation. ( Blazar, B; Bostrom, B; Bruns, A; Enockson, K; Johnson, A, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (21.05) | 18.7374 |
| 1990's | 3 (15.79) | 18.2507 |
| 2000's | 5 (26.32) | 29.6817 |
| 2010's | 5 (26.32) | 24.3611 |
| 2020's | 2 (10.53) | 2.80 |
| Authors | Studies |
|---|---|
| Carruthers, VA | 1 |
| Lum, SH | 1 |
| Flood, T | 3 |
| Slatter, MA | 4 |
| Gennery, AR | 4 |
| Martuszewski, A | 2 |
| Paluszkiewicz, P | 2 |
| Wawrzyniak-Dzierżek, E | 2 |
| Drożyńska-Duklas, M | 1 |
| Bąbol-Pokora, K | 2 |
| Myśliwiec, M | 1 |
| Szymczak, D | 1 |
| Irga-Jaworska, N | 1 |
| Młynarski, W | 2 |
| Kałwak, K | 2 |
| Ussowicz, M | 2 |
| Sierżęga-Staykov, K | 1 |
| Salamonowicz-Bodzioch, M | 1 |
| Frączkiewicz, J | 1 |
| Janeczko-Czarnecka, M | 1 |
| Mielcarek-Siedziuk, M | 1 |
| Nowak, M | 1 |
| Dąbrowska-Leonik, N | 1 |
| Wolska-Kuśnierz, B | 1 |
| Gul, K | 1 |
| Ishiwata, Y | 1 |
| Nagata, M | 1 |
| Tsuge, K | 1 |
| Takahashi, H | 1 |
| Suzuki, S | 1 |
| Imai, K | 1 |
| Takagi, M | 1 |
| Kanegane, H | 1 |
| Morio, T | 2 |
| Yasuhara, M | 1 |
| Rao, K | 2 |
| Abd Hamid, IJ | 1 |
| Nademi, Z | 2 |
| Chiesa, R | 1 |
| Elfeky, R | 1 |
| Pearce, MS | 1 |
| Amrolia, P | 2 |
| Worth, A | 1 |
| Abinun, M | 3 |
| Hambleton, S | 2 |
| Qasim, W | 2 |
| Gaspar, HB | 2 |
| Cant, AJ | 2 |
| Veys, P | 2 |
| Haskoloğlu, Ş | 1 |
| Köstel Bal, S | 1 |
| İslamoğlu, C | 1 |
| Altun, D | 1 |
| Kendirli, T | 1 |
| Doğu, EF | 1 |
| İkincioğulları, A | 1 |
| Goulden, N | 1 |
| Davies, G | 1 |
| Cant, A | 1 |
| Bostrom, B | 1 |
| Enockson, K | 1 |
| Johnson, A | 1 |
| Bruns, A | 1 |
| Blazar, B | 1 |
| Nagasawa, M | 1 |
| Itoh, S | 1 |
| Sawada, Y | 1 |
| Nonoyama, S | 1 |
| Mizutani, S | 1 |
| Cheetham, TD | 1 |
| Bhattacharya, A | 1 |
| Crooks, BN | 1 |
| Flood, TJ | 1 |
| Bakker, B | 1 |
| Oostdijk, W | 1 |
| Bresters, D | 1 |
| Walenkamp, MJ | 1 |
| Vossen, JM | 2 |
| Wit, JM | 1 |
| Ariga, T | 1 |
| van Tol, MJ | 1 |
| Gerritsen, EJ | 1 |
| de Lange, GG | 1 |
| van Leeuwen, AM | 1 |
| Jol-van der Zijde, CM | 1 |
| Oudeman-Gruber, NJ | 1 |
| de Vries, E | 1 |
| Radl, J | 1 |
| Basch, RS | 1 |
| Quito, FL | 1 |
| Beh, J | 1 |
| Hirst, JA | 1 |
| Storb, R | 1 |
| Weiden, PL | 1 |
| Graham, TC | 1 |
| Thomas, ED | 1 |
| Guseva, SA | 1 |
| Hobbs, JR | 1 |
| Hugh-Jones, K | 1 |
| Pawelec, G | 1 |
| Schmidt, H | 1 |
| Schneider, E | 1 |
| Bühring, HJ | 1 |
| Ehninger, G | 1 |
| Marcovitch, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Evaluation of Treosulfan Pharmacokinetics (PK) in Children Undergoing Allogeneic Haematopoietic Stem Cell Transplantation (HSCT)[NCT02048800] | 61 participants (Actual) | Observational | 2014-03-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for busulfan and Antibody Deficiency Syndrome
| Article | Year |
|---|---|
[Gene therapy for primary immunodeficiency diseases].
Topics: Adaptor Proteins, Signal Transducing; Adenosine Deaminase; Busulfan; DNA-Binding Proteins; Genetic T | 2005 |
Studies of marrow transplantation in dogs.
Topics: Adenocarcinoma; Anal Gland Neoplasms; Animals; Blood Transfusion; Bone Marrow Cells; Bone Marrow Tra | 1976 |
2 trials available for busulfan and Antibody Deficiency Syndrome
| Article | Year |
|---|---|
Treosulfan and Fludarabine Conditioning for Hematopoietic Stem Cell Transplantation in Children with Primary Immunodeficiency: UK Experience.
Topics: Adolescent; Adult; Alemtuzumab; Allografts; Busulfan; Child; Child, Preschool; Disease-Free Survival | 2018 |
[Characteristics of the effect of myelosan on the immune status of patients with chronic myeloid leukemia].
Topics: Adjuvants, Immunologic; B-Lymphocytes; Busulfan; Humans; Immunity; Immunoglobulins; Immunologic Defi | 1992 |
15 other studies available for busulfan and Antibody Deficiency Syndrome
| Article | Year |
|---|---|
Hematopoietic Cell Transplant for CD40 Ligand Deficiency-Comparing Busulfan Versus Treosulfan.
Topics: Antineoplastic Agents, Alkylating; Busulfan; CD40 Ligand; Hematopoietic Stem Cell Transplantation; H | 2022 |
Successful Salvage Haploidentical Alpha-Beta T Cell-Depleted Stem Cell Transplantation After Busulfan-Based Myeloablation in a Patient With IPEX Syndrome: A Case Report.
Topics: Antilymphocyte Serum; Busulfan; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Huma | 2019 |
Successful Allogeneic Stem Cell Transplantation in Nuclear Factor-Kappa B Essential Modulator Deficiency Syndrome After Treosulfan-Based Conditioning: A Case Report.
Topics: Antilymphocyte Serum; Busulfan; Ectodermal Dysplasia; Hematopoietic Stem Cell Transplantation; Human | 2020 |
Population Pharmacokinetics of Intravenous Busulfan in Japanese Pediatric Patients With Primary Immunodeficiency Diseases.
Topics: Administration, Intravenous; Adolescent; Asian People; Busulfan; Child; Child, Preschool; Female; He | 2018 |
Outcome of treosulfan-based reduced-toxicity conditioning regimens for HSCT in high-risk patients with primary immune deficiencies.
Topics: Adolescent; Busulfan; Child; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combinati | 2018 |
Treosulfan-based conditioning regimens for hematopoietic stem cell transplantation in children with primary immunodeficiency: United Kingdom experience.
Topics: Adolescent; Antineoplastic Agents, Alkylating; Busulfan; Child; Child, Preschool; Chimerism; Cohort | 2011 |
Plasma pharmacokinetics of high-dose oral busulfan in children and adults undergoing bone marrow transplantation.
Topics: Adolescent; Adult; Area Under Curve; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; | 2003 |
Coagulopathy in a patient with X-linked hyper-IgM syndrome who developed Kaposi's sarcoma.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Chromos | 2004 |
Thyroid dysfunction after bone marrow transplantation for primary immunodeficiency without the use of total body irradiation in conditioning.
Topics: Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Cyclophosphamide; Female; Humans; Hy | 2004 |
Disturbances of growth and endocrine function after busulphan-based conditioning for haematopoietic stem cell transplantation during infancy and childhood.
Topics: Adolescent; Antineoplastic Agents, Alkylating; Body Height; Busulfan; Calcium; Child; Child, Prescho | 2004 |
The origin of IgG production and homogeneous IgG components after allogeneic bone marrow transplantation.
Topics: Anemia, Aplastic; B-Lymphocytes; Bone Marrow; Bone Marrow Transplantation; Busulfan; Cell Survival; | 1996 |
Growth of human hematopoietic cells in immunodeficient mice conditioned with cyclophosphamide and busulfan.
Topics: Adult; Animals; Antigens, CD34; Bone Marrow; Bone Marrow Cells; Busulfan; Cell Count; Cell Division; | 1997 |
Immunodeficiencies better treated by transplantation.
Topics: B-Lymphocytes; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Fetus; Haploidy; Histocompat | 1985 |
Cellular immunological defects of chronic myelogenous leukaemics: partial dependence on busulphan therapy.
Topics: Antigens, Differentiation; Antigens, Surface; Busulfan; HLA-DP Antigens; HLA-DR Antigens; Humans; Im | 1988 |
Chronic granulomatous disease of childhood.
Topics: Anti-Bacterial Agents; Busulfan; Child; Child, Preschool; Chronic Disease; Coloring Agents; Female; | 1970 |